NCT00103428 Intravenous CG7870 in Combination With Docetaxel in Patients With Metastatic Hormone-Refractory Prostate Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT00103376 Bortezomib With or Without Hormone Therapy in Treating Patients With Relapsed Prostate Cancer Status TERMINATED Phase PHASE2
NCT00102544 Use of Tracking Devices to Locate Abnormalities During Invasive Procedures Status ENROLLING_BY_INVITATION Phase NA
NCT00100243 Study of Abarelix in Androgen-Independent Prostate Cancer Progressing After Agonist Therapy Status COMPLETED Phase PHASE2
NCT00099086 Docetaxel, Radiation Therapy, and Hormone Therapy in Treating Patients With Locally Advanced Prostate Cancer Status COMPLETED Phase PHASE1
NCT00096304 Epirubicin and Docetaxel in Treating Patients With Metastatic Prostate Cancer Status TERMINATED Phase PHASE1
NCT00093561 Lycopene in Preventing Prostate Cancer in Healthy Participants Status COMPLETED Phase PHASE1
NCT00093457 Sorafenib in Treating Patients With Metastatic or Recurrent Prostate Cancer Status COMPLETED Phase PHASE2
NCT00091390 Radiation Therapy in Treating Patients With Stage II or Stage III Prostate Cancer Status COMPLETED Phase PHASE2
NCT00090545 A Phase II Study of BAY 43-9006 (Sorafenib) in Metastatic, Androgen-Independent Prostate Cancer Status COMPLETED Phase PHASE2
NCT00090376 Evaluate the Effects of GPI 1485 on Erectile Function Following Bilateral Nerve-Sparing Prostatectomy Status COMPLETED Phase PHASE2
NCT00090363 ZD4054 (Zibotentan) in Pain-free or Mildly Symptomatic Patients With Prostate Cancer and Bone Metastases Who Have Rising Serum Prostate Specific Antigen (PSA) Status COMPLETED Phase PHASE2
NCT00089856 GVAX® Vaccine for Prostate Cancer vs Docetaxel & Prednisone in Patients With Metastatic Hormone-Refractory Prostate Cancer Status TERMINATED Phase PHASE3
NCT00089674 AMG 162 in the Treatment of Bone Loss in Subjects Undergoing Androgen-Deprivation Therapy for Non-metastatic Prostate Cancer Status COMPLETED Phase PHASE3
NCT00087854 Study of Individualized Amonafide to Treat Prostate Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00087659 A Prostate Cancer Study in Men Undergoing Androgen Deprivation Therapy Status COMPLETED Phase NA
NCT00087347 Magnetic Resonance Imaging of Lymph Nodes Using Ferumoxytol in Patients With Primary Prostate or Breast Cancer Status COMPLETED Phase N/A
NCT00087165 GTI-2040, Docetaxel, and Prednisone in Treating Patients With Prostate Cancer Status COMPLETED Phase PHASE2
NCT00087035 Docetaxel and Erlotinib in Treating Older Patients With Prostate Cancer Status COMPLETED Phase PHASE2
NCT00086762 Mindfulness Relaxation Compared With Relaxing Music and Standard Symptom Management Education in Treating Patients Who Are Undergoing Chemotherapy For Newly Diagnosed Solid Tumors Status COMPLETED Phase NA